Delivery Order SPE2DB20D1102-SPE2DB25FC5YR

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.70 firm fixed-price delivery order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,420.26 firm-fixed-price delivery order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products, with a period of performance through November 25, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,257.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies, with a performance period running through January 17, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a ceiling value of $2,998.89 and a completion date of September 27, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,245.82 firm fixed-price delivery order contract provides PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, to support defense and military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $1,108.96 firm fixed-price delivery order has a completion date of November 15, 2024 and is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. is a Delivery Order with a Firm Fixed Price valued at $1,761.96. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical supply item, with a completion date of January 10, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that runs through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a ceiling value of $1,063.73 and a completion date of August 6, 2024. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract is a firm fixed-price delivery order with a ceiling value of $2,133.88 and an ultimate completion date of August 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,279.49, is a Delivery Order for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of January 30, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC5YR
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The firm-fixed-price delivery order, valued at $2,617.68, has an ultimate completion date of February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract did not have a set-aside designation, indicating open competition.

Generated 5/6/25, 9:58 AM